Federal Register #2026-13580

DEA Proposes Temporary Schedule I Placement of 7-hydroxymitragynine Above Threshold

This notice from the Drug Enforcement Administration (DEA) announces a proposed regulatory action regarding 7-hydroxymitragynine: - The DEA, under the Department of Justice, intends to temporarily place 7-hydroxymitragynine (including its isomers, esters, ethers, and salts) above a specified threshold into Schedule I of the Controlled Substances Act - This is a regulatory notice, not a procurement or solicitation for products or services - No OEMs, vendors, or commercial products are mentioned or requested - The action aims to impose regulatory controls and sanctions on the manufacture, distribution, import, export, research, and possession of 7-hydroxymitragynine above the defined threshold - The notice details chemical definitions, public health risks, and regulatory background - Public comment is invited on the proposed scheduling - No products, part numbers, or service requirements are included

Description

This notice proposes the temporary scheduling of 7-hydroxymitragynine, including its isomers, esters, ethers, and salts, above a specified threshold in Schedule I of the Controlled Substances Act. The temporary scheduling order will impose regulatory controls and sanctions on persons who handle or propose to handle the substance above the specified threshold. The regulation aims to address the public safety risks posed by the uncontrolled manufacture, distribution, and abuse of 7-hydroxymitragynine. Comments on the proposal can be submitted via the provided regulation URL.

View original listing